Navigation Links
A genetic 'gang of 4' drives spread of breast cancer

Studies of human tumor cells implanted in mice have shown that the abnormal activation of four genes drives the spread of breast cancer to the lungs. The new studies by Howard Hughes Medical Institute researchers reveal that the aberrant genes work together to promote the growth of primary breast tumors. Cooperation among the four genes also enables cancerous cells to escape into the bloodstream and penetrate through blood vessels into lung tissues.

Although shutting off these genes individually can slow cancer growth and metastasis, the researchers found that turning off all four together had a far more dramatic effect on halting cancer growth and metastasis. Metastasis occurs when cells from a primary tumor break off and invade another organ. It is the deadliest transformation that a cancer can undergo, and therefore researchers have been looking for specific genes that propel metastasis.

In the newly published experiments, the researchers also found that they could reduce the growth and spread of human breast tumors in mice by simultaneously targeting two of the proteins produced by these genes, using drugs already on the market. The researchers are exploring clinical testing of combination therapy with the drugs—cetuximab (trade name Erbitux) and celecoxib (Celebrex)—to treat breast cancer metastasis.

The research team, led by Howard Hughes Medical Institute investigator Joan Massagué at the Memorial Sloan-Kettering Cancer Center, published its findings in articles in the April 12, 2007, issue of the journal Nature and in the online early edition of the Proceedings of the National Academy of Sciences on April 9, 2007.

In an earlier study, Massagué and his colleagues had identified 18 genes whose abnormal activity is associated with breast cancer’s ability to spread to the lungs. In the new study published in Nature, Massagué and his colleagues at Sloan-Kettering, along with researchers from Hospital Clinic de Barcelona and the
'"/>

Source:Howard Hughes Medical Institute


Page: 1 2 3 4

Related biology news :

1. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
2. Scientists detect probable genetic cause of some Parkinsons disease cases
3. Mouse brain tumors mimic those in human genetic disorder
4. Scientists identify genetic pathways essential to RNA interference
5. Researchers trace evolution to relatively simple genetic changes
6. Key mechanism in genetic inheritance during cell division identified
7. Scientists identify genetic pathways essential to RNA interference
8. MUHC scientists describe genetic resistance to rampant virus
9. Mosaic mouse technique offers a powerful new tool to study diseases and genetics
10. Montreal researchers probe the genetic basis of memory
11. Biologists determine genetic blueprint of social amoeba
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: genetic gang drives spread breast cancer

(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... advances in technology, it is important to upgrade biometric ...
(Date:12/11/2014)... 2014  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... As any rock-climber knows, trailing a long length of rope ... is unwieldy and hard to manoeuvre, and can get tangled ... problem when dragging chromosomes apart during cell division. The chromosomes ... arms trailing along behind. Just like climbers carry their rope ...
... Researchers at UT Southwestern Medical Center say there are ... of colon cancer, far more than scientists previously thought. ... July 2011 Cancer Research (Priority Reports), researchers are suggesting ... genes and pathways simultaneously. Current cancer treatments target just ...
... Africa are generating a high amount of pollution that is ... ominous shape of a dark red butterfly in the skies ... and northern Angola. An image of the pollution from ... nitrogen dioxide (NO2) levels over the period from July 7 ...
Cached Biology News:Keeping it together 2NASA's Aura satellite measures pollution 'butterfly' from fires in central Africa 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Controlled Substance ... Alliance, which helps companies check the legal requirements around ... expand to China. , As their international operations ... globally adopting software solutions built as a result of ...
(Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
(Date:12/24/2014)... Md. , Dec. 24, 2014  United Therapeutics Corporation ... Inc. (NYSE: MDT ) has submitted a ... Administration (FDA) for the use of Medtronic,s SynchroMed ® ... developed catheter) for use with United Therapeutics, Remodulin ® ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... -- WuXi PharmaTech (NYSE:,WX), a leading pharmaceutical, biotechnology and ... China and the United,States, announced today that it will ... WuXi will maintain its original plan to construct, own,and ... China which is,slated to open in the second half ...
... Cell Therapeutics, Inc.,("CTI" or the "Company") (Nasdaq: CTICD ... investor shall purchase, for $14.2 million, newly,issued 15.5% Convertible ... per share. The transaction is the result of an ... September 26, 2008) under which,the investor had purchased $9 ...
... Australia, Sept. 26 A non-invasive blood,monitoring device ... monitor patients,has won the 2008 Kerrin Rennie Award ... to Masimo Corporation on 24 September at the,Medical ... The Radical-7 Pulse CO-Oximeter from Masimo Corporation ...
Cached Biology Technology:WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 3No Blood Needed Thanks to Innovative Medical Technology 2
Digital display of time, vacuum and temperature , Dual vacuum control of ramping rate and ultimate level , Comes complete with RH40-12 (40 x 1.5 ml) Rotor and (2) Glass Condensation Flasks. ...
... SpeedVac Model SPD131DDA , Our most chemically ... designed to handle the rigors and solvents of ... digital display, dual independent timers, an automatic bleeder ... vapor pathway. , , Adjustable Vacuum Level ...
... concentrator for efficient drying of small volumes ... system combines the SpeedVac™ Concentrator and chemically ... pump and rotor control, and dual timers ... time), makes the DNA120 indispensable in the ...
... The University of New South Wales, Sydney, Australia ... Australia This is the Fourth Edition of this ... is a large format version (330 x ... 3rd edition. This product number includes the ...
Biology Products: